Tiletamine Hcl;Zolazapam Hcl
300 adverse event reports submitted to the FDA
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
300
Total Reports
72
Deaths Reported
2400.0%
Death Rate
Active Ingredients
Tiletamine Hcl;Zolazapam Hcl
Administration Routes
IntramuscularUnknownIntravenousSubcutaneousOphthalmicOralOther
Species Affected
Dog 146
Cat 105
Unknown 35
Human 6
Monkey 2
Horse 2
Other 1
Tiger 1
Pig 1
Bear 1
Most Affected Breeds
Domestic Shorthair 59
Unknown 46
Dog (unknown) 39
Cat (other) 33
Retriever - Labrador 12
Terrier - Bull - American Pit 10
Shepherd Dog - German 6
Domestic Mediumhair 6
Terrier - Yorkshire 5
Terrier (unspecified) 5
Most Reported Reactions
Lack of efficacy - NOS 72
Death 41
Unrelated death 19
Cardiac arrest 18
Ataxia 17
Lethargy (see also Central nervous system depression in 'Neurological') 16
Recovery prolonged 16
Vomiting 15
Color, Abnormal 13
Bradycardia 13
Cyanosis 13
Tachycardia 12
Outcome Breakdown
Recovered/Normal
96 (35.8%)
Ongoing
77 (28.7%)
Died
44 (16.4%)
Euthanized
28 (10.4%)
Outcome Unknown
23 (8.6%)
Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.